Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities - PubMed (original) (raw)
Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities
D M Parry et al. Am J Hum Genet. 1996 Sep.
Abstract
Neurofibromatosis 2 (NF2) features bilateral vestibular schwannomas, other benign neural tumors, and cataracts. Patients in some families develop many tumors at an early age and have rapid clinical progression, whereas in other families, patients may not have symptoms until much later and vestibular schwannomas may be the only tumors. The NF2 gene has been cloned from chromosome 22q; most identified germ-line mutations result in a truncated protein and severe NF2. To look for additional mutations and clinical correlations, we used SSCP analysis to screen DNA from 32 unrelated patients. We identified 20 different mutations in 21 patients (66%): 10 nonsense mutations, 2 frameshifts, 7 splice-site mutations, and 1 large in-frame deletion. Clinical information on 47 patients from the 21 families included ages at onset and at diagnosis, numbers of meningiomas, spinal and skin tumors, and presence of cataracts and retinal abnormalities. We compared clinical findings in patients with nonsense or frameshift mutations to those with splice-site mutations. When each patient was considered as an independent random event, the two groups differed (P < or = .05) for nearly every variable. Patients with nonsense or frameshift mutations were younger at onset and at diagnosis and had a higher frequency and mean number of tumors, supporting the correlation between nonsense and frameshift mutations and severe NF2. When each family was considered as an independent random event, statistically significant differences between the two groups were observed only for mean ages at onset and at diagnosis. A larger data set is needed to resolve these discrepancies. We observed retinal hamartomas and/or epiretinal membranes in nine patients from five families with four different nonsense mutations. This finding, which may represent a new genotype-phenotype correlation, merits further study.
Similar articles
- Correlation of nonsense and frameshift mutations with severity of retinal abnormalities in neurofibromatosis 2.
Feucht M, Kluwe L, Mautner VF, Richard G. Feucht M, et al. Arch Ophthalmol. 2008 Oct;126(10):1376-80. doi: 10.1001/archopht.126.10.1376. Arch Ophthalmol. 2008. PMID: 18852415 - Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes.
Kluwe L, Bayer S, Baser ME, Hazim W, Haase W, Fünsterer C, Mautner VF. Kluwe L, et al. Hum Genet. 1996 Nov;98(5):534-8. doi: 10.1007/s004390050255. Hum Genet. 1996. PMID: 8882871 - Further genotype--phenotype correlations in neurofibromatosis 2.
Selvanathan SK, Shenton A, Ferner R, Wallace AJ, Huson SM, Ramsden RT, Evans DG. Selvanathan SK, et al. Clin Genet. 2010 Feb;77(2):163-70. doi: 10.1111/j.1399-0004.2009.01315.x. Epub 2009 Nov 23. Clin Genet. 2010. PMID: 19968670 - Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
Kley N, Whaley J, Seizinger BR. Kley N, et al. Glia. 1995 Nov;15(3):297-307. doi: 10.1002/glia.440150310. Glia. 1995. PMID: 8586465 Review. - CNS Young Investigator Award Lecture: molecular analysis of the neurofibromatosis 2 tumor suppressor.
MacCollin M. MacCollin M. Brain Dev. 1995 Jul-Aug;17(4):231-8. doi: 10.1016/0387-7604(95)00044-c. Brain Dev. 1995. PMID: 7503383 Review.
Cited by
- Managing NF2-associated vestibular schwannomas in children and young adults: review of an institutional series regarding effects of surgery and bevacizumab on growth rates, tumor volume, and hearing quality.
Gugel I, Zipfel J, Hartjen P, Kluwe L, Tatagiba M, Mautner VF, Schuhmann MU. Gugel I, et al. Childs Nerv Syst. 2020 Oct;36(10):2471-2480. doi: 10.1007/s00381-020-04728-x. Epub 2020 Jun 16. Childs Nerv Syst. 2020. PMID: 32548671 Free PMC article. - Cerebrovascular Insult as Presenting Symptom of Neurofibromatosis Type 2 in Children, Adolescents, and Young Adults.
Gugel I, Mautner VF, Kluwe L, Tatagiba MS, Schuhmann MU. Gugel I, et al. Front Neurol. 2018 Sep 10;9:733. doi: 10.3389/fneur.2018.00733. eCollection 2018. Front Neurol. 2018. PMID: 30250447 Free PMC article. - An ELISA-based high throughput protein truncation test for inherited breast cancer.
Lim MJ, Foster GJ, Gite S, Ostendorff HP, Narod S, Rothschild KJ. Lim MJ, et al. Breast Cancer Res. 2010;12(5):R78. doi: 10.1186/bcr2722. Epub 2010 Oct 4. Breast Cancer Res. 2010. PMID: 20920338 Free PMC article. - Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis.
Jacoby LB, Jones D, Davis K, Kronn D, Short MP, Gusella J, MacCollin M. Jacoby LB, et al. Am J Hum Genet. 1997 Dec;61(6):1293-302. doi: 10.1086/301633. Am J Hum Genet. 1997. PMID: 9399891 Free PMC article. - Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein.
Giovannini M, Robanus-Maandag E, Niwa-Kawakita M, van der Valk M, Woodruff JM, Goutebroze L, Mérel P, Berns A, Thomas G. Giovannini M, et al. Genes Dev. 1999 Apr 15;13(8):978-86. doi: 10.1101/gad.13.8.978. Genes Dev. 1999. PMID: 10215625 Free PMC article.
References
- Arch Neurol. 1969 Feb;20(2):154-60 - PubMed
- Am J Hum Genet. 1994 Aug;55(2):314-20 - PubMed
- Birth Defects Orig Artic Ser. 1974;10(10):171-84 - PubMed
- Arch Ophthalmol. 1977 Nov;95(11):1990-2 - PubMed
- Neurology. 1980 Aug;30(8):851-9 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous